INTERNATIONAL PATENT: SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD., 上海复星医药（集团）股份有限公司 FILES APPLICATION FOR "NITROGEN-CONTAINING TRICYCLIC DERIVATIVE AS PARG INHIBITOR"

GENEVA, June 2 -- SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. (Building A, No. 1289 Yishan RoadXuhui District, Shanghai 200233), 上海复星医药（集团）股份有限公司 (中国上海市徐汇区宜山路1289号A楼) filed a patent application (PCT/CN2024/132642) for "NITROGEN-CONTAINING TRICYCLIC DERIVATIVE AS PARG INHIBITOR" on Nov 18, 2024. With publication no. WO/2025/108225, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the Wo...